EMAIL THIS PAGE TO A FRIEND

British journal of cancer

Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity.


PMID 26135897

Abstract

Alterations in connexin 43 (Cx43) expression and/or gap junction (GJ)-mediated intercellular communication are implicated in cancer pathogenesis. Herein, we have investigated the role of Cx43 in melanoma cell proliferation and apoptosis sensitivity in vitro, as well as metastatic capability and tumour growth in vivo. Connexin 43 expression levels, GJ coupling and proliferation rates were analysed in four different human melanoma cell lines. Furthermore, tumour growth and lung metastasis of high compared with low Cx43-expressing FMS cells were evaluated in vivo using a melanoma xenograft model. Specific inhibition of Cx43 channel activity accelerated melanoma cell proliferation, whereas overexpression of Cx43 increased GJ coupling and reduced cell growth. Moreover, Cx43 overexpression in FMS cells increased basal and tumour necrosis factor-α-induced apoptosis and resulted in decreased melanoma tumour growth and lower number and size of metastatic foci in vivo. Our findings reveal an important role for Cx43 in intrinsically controlling melanoma growth, death and metastasis, and emphasise the potential use of compounds that selectively enhance Cx43 expression on melanoma in the future chemotherapy and/or immunotherapy protocols.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4501173
Anti-Connexin 43 antibody produced in rabbit, affinity isolated antibody
SAB4501174
Anti-Connexin 43, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4501175
Anti-Connexin 43, C-Terminal antibody produced in rabbit, affinity isolated antibody
C6219
Anti-Connexin-43 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4300504
Anti-GJA1 (Ab-367) antibody produced in rabbit, affinity isolated antibody
SAB2501246
Anti-GJA1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
AV36598
Anti-GJA1 antibody produced in rabbit, affinity isolated antibody
SAB2900237
Anti-GJA1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2100918
Anti-GJA1 antibody produced in rabbit, affinity isolated antibody
SAB1300558
Anti-GJA3 (C-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1300557 Anti-GJA3 (N-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB2100919
Anti-GJA3 antibody produced in rabbit, affinity isolated antibody
SAB4501178
Anti-GJA3 antibody produced in rabbit, affinity isolated antibody
SAB4500949
Anti-MART-1 antibody produced in rabbit, affinity isolated antibody
HPA048662
Anti-MLANA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C1359
Calcein AM solution, 4 mM in DMSO, ≥90% (HPLC), solution
C46H46N2O23
17783
Calcein-AM, BioReagent, suitable for fluorescence, ≥96.0% (HPLC)
C46H46N2O23
56496
Calcein-AM, Small Package (20 X 50 μg ), ≥96.0% (HPCE)
C46H46N2O23
WH0002697M1
Monoclonal Anti-GJA1 antibody produced in mouse, clone 3E5, purified immunoglobulin, buffered aqueous solution
M6570
Monoclonal Anti-Melan-A antibody produced in mouse, ~2 mg/mL, clone A103, purified immunoglobulin, buffered aqueous solution